Bharat Immunologicals Corporate Bonds and Current Financial Leverage

BIBCL -- India Stock  

INR 8.70  0.30  3.33%

Bharat Immunologicals financial leverage is the degree to which the firm utilises its fixed-income securities. Companies with high leverage are usually considered to be at financial risk. Bharat Immunologicals financial risk is the risk to Bharat Immunologicals stockholders that is caused by an increase in debt. In other words with a high degree of financial leverage come high interest payments which usually reduces Earnings Per Share (EPS). Check also analysis of Bharat Immunologicals Fundamentals Over Time.

Bharat Immunologicals Financial Leverage Rating

Not Rated
Total Macroaxis Rating
Average S&P Rating

Bharat Immunologicals Debt to Cash Allocation

The company has accumulated zero balance in total debt with debt to equity ratio (D/E) of 3.8 implying the company greatly relies on financing operations through barrowing. Bharat Immunologicals has Current Ratio of 1.75 which is within standard range for the sector.

Current Sentiment - BIBCL

Bharat Immunologicals Investor Sentiment

Most of Macroaxis users are currently bullish on Bharat Immunologicals Biologicals Corp Ltd. What is your opinion about investing in Bharat Immunologicals Biologicals Corp Ltd? Are you bullish or bearish?
98% Bullish
2% Bearish

Bharat Immunologicals Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Bharat Immunologicals and Biocon Limited. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also analysis of Bharat Immunologicals Fundamentals Over Time. Please also try Portfolio Manager module to state of the art portfolio manager to monitor and improve performance of your invested capital.